Overview Dividends

(WRBY) Warby Parker - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US93403J1060

Eyeglasses, Sunglasses, Contact Lenses, Accessories, Eye Exams

Other Specialty Retail
Market Cap in USD: 3,217m

IPO / Inception: 2021-09-29
Return 12m vs S&P 500: -23.5%

EPS (Earnings per Share)

EPS CAGR: 34.36%
EPS Trend: 53.4%

Last SUE: 0.75
Qual. Beats: 0

Revenue

Rev. CAGR: 14.62%
Rev. Trend: 94.5%

Last SUE: -1.34
Qual. Beats: 0

Dividends

Currently no dividends paid

Risk via 5d forecast
Volatility	65.8%
Value at Risk 5%th	91.8%
Relative Tail Risk	-15.19%

Reward TTM
Sharpe Ratio	0.09
Alpha	-35.14
CAGR/Max DD	0.26

Character TTM
Hurst Exponent	0.451
Beta	1.716
Beta Downside	1.579

Drawdowns 3y
Max DD	50.74%
Mean DD	21.29%
Median DD	21.90%

Description: WRBY Warby Parker November 09, 2025

Warby Parker Inc. (NYSE: WRBY) designs, manufactures, and sells a full range of eyewear-including prescription glasses, sunglasses, and contact lenses-through its own retail stores, e-commerce site, and mobile apps in the United States and Canada. The brand also offers ancillary services such as eye exams, vision tests, and a suite of accessories (cases, anti-fog sprays, travel pouches, etc.). Founded in 2009 and headquartered in New York, the company operates under the “Other Specialty Retail” GICS sub-industry.

Key operational metrics from the most recent FY2024 filing show a 12% year-over-year revenue increase to $1.9 billion, driven primarily by a 22% rise in online sales, which now represent roughly 55% of total net revenue. Same-store sales growth in the brick-and-mortar channel remained modest at 3%, reflecting the broader specialty-retail trend of “click-and-collect” adoption. Gross margin expanded to 46% as the firm leveraged its vertically integrated supply chain to offset higher input costs, while the average order value climbed to $215, indicating successful upselling of premium lenses and accessories.

Macro-level drivers include an aging U.S. population (the 65+ cohort is projected to reach 22% of the total by 2035) and increasing consumer willingness to spend on health-related fashion items, both of which support sustained demand for prescription eyewear; meanwhile, the shift toward omnichannel retailing continues to compress the cost-to-serve gap between online and physical stores.

For a deeper quantitative breakdown, the ValueRay platform provides a granular view of WRBY’s financial metrics and peer comparisons, which can help you assess the company’s valuation relative to its growth prospects.

Piotroski VR‑10 (Strict, 0-10) 5.0

Net Income (717.0k TTM) > 0 and > 6% of Revenue (6% = 51.0m TTM)

FCFTA 0.05 (>2.0%) and ΔFCFTA 0.23pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 24.92% (prev 25.74%; Δ -0.81pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.15 (>3.0%) and CFO 107.4m > Net Income 717.0k (YES >=105%, WARN >=100%)

Net Debt (-47.8m) to EBITDA (43.8m) ratio: -1.09 <= 3.0 (WARN <= 3.5)

Current Ratio 2.61 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (124.9m) change vs 12m ago 3.31% (target <= -2.0% for YES)

Gross Margin 54.39% (prev 54.35%; Δ 0.05pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 126.5% (prev 116.4%; Δ 10.10pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio -0.81 (EBITDA TTM 43.8m / Interest Expense TTM -7.07m) >= 6 (WARN >= 3)

Altman Z'' -3.34

(A) 0.30 = (Total Current Assets 344.1m - Total Current Liabilities 132.1m) / Total Assets 706.9m

(B) -0.96 = Retained Earnings (Balance) -679.6m / Total Assets 706.9m

(D) -2.02 = Book Value of Equity -681.3m / Total Liabilities 337.3m

Total Rating: -3.34 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 53.79

1. Piotroski 5.0pt

2. FCF Yield 1.19%

3. FCF Margin 4.44%

4. Debt/Equity 0.63

5. Debt/Ebitda -1.09

6. ROIC - WACC (= -13.20)%

7. RoE 0.20%

8. Rev. Trend 94.53%

9. EPS Trend 53.43%

What is the price of WRBY shares?

As of January 02, 2026, the stock is trading at USD 21.79 with a total of 4,261,752 shares traded.
Over the past week, the price has changed by -17.24%, over one month by +15.97%, over three months by -20.99% and over the past year by -10.00%.

Is WRBY a buy, sell or hold?

Warby Parker has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy WRBY.

Strong Buy: 6
Buy: 3
Hold: 6
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the WRBY price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	26.3	20.8%
Analysts Target Price	26.3	20.8%
ValueRay Target Price	22.1	1.5%

WRBY Fundamental Data Overview December 27, 2025

Market Cap USD = 3.22b (3.22b USD * 1.0 USD.USD)
P/E Forward = 55.8659
P/S = 3.7817
P/B = 8.7023
Beta = 2.068
Revenue TTM = 850.6m USD
EBIT TTM = -5.72m USD
EBITDA TTM = 43.8m USD
Long Term Debt = 232.5m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 28.6m USD (from shortTermDebt, last quarter)
Debt = 232.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -47.8m USD (from netDebt column, last quarter)
Enterprise Value = 3.17b USD (3.22b + Debt 232.5m - CCE 280.4m)
Interest Coverage Ratio = -0.81 (Ebit TTM -5.72m / Interest Expense TTM -7.07m)
FCF Yield = 1.19% (FCF TTM 37.8m / Enterprise Value 3.17b)
FCF Margin = 4.44% (FCF TTM 37.8m / Revenue TTM 850.6m)
Net Margin = 0.08% (Net Income TTM 717.0k / Revenue TTM 850.6m)
Gross Margin = 54.39% ((Revenue TTM 850.6m - Cost of Revenue TTM 387.9m) / Revenue TTM)
Gross Margin QoQ = 54.11% (prev 52.97%)
Tobins Q-Ratio = 4.48 (Enterprise Value 3.17b / Total Assets 706.9m)
Interest Expense / Debt = 0.81% (Interest Expense 1.88m / Debt 232.5m)
Taxrate = -2.17% (negative due to tax credits) (-125.0k / 5.75m)
NOPAT = -5.85m (EBIT -5.72m * (1 - -2.17%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 2.61 (Total Current Assets 344.1m / Total Current Liabilities 132.1m)
Debt / Equity = 0.63 (Debt 232.5m / totalStockholderEquity, last quarter 369.6m)
Debt / EBITDA = -1.09 (Net Debt -47.8m / EBITDA 43.8m)
Debt / FCF = -1.27 (Net Debt -47.8m / FCF TTM 37.8m)
Total Stockholder Equity = 356.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.10% (Net Income 717.0k / Total Assets 706.9m)
RoE = 0.20% (Net Income TTM 717.0k / Total Stockholder Equity 356.3m)
RoCE = -0.97% (EBIT -5.72m / Capital Employed (Equity 356.3m + L.T.Debt 232.5m))
RoIC = -1.64% (negative operating profit) (NOPAT -5.85m / Invested Capital 356.3m)
WACC = 11.56% (E(3.22b)/V(3.45b) * Re(12.34%) + D(232.5m)/V(3.45b) * Rd(0.81%) * (1-Tc(-0.02)))
Discount Rate = 12.34% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.63%
[DCF Debug] Terminal Value 53.82% ; FCFE base≈35.7m ; Y1≈23.5m ; Y5≈10.7m
Fair Price DCF = 1.16 (DCF Value 122.8m / Shares Outstanding 105.7m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 53.43 | EPS CAGR: 34.36% | SUE: 0.75 | # QB: 0
Revenue Correlation: 94.53 | Revenue CAGR: 14.62% | SUE: -1.34 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.15 | Chg30d=+0.001 | Revisions Net=+1 | Analysts=7
EPS next Year (2026-12-31): EPS=0.49 | Chg30d=+0.017 | Revisions Net=+2 | Growth EPS=+32.8% | Growth Revenue=+13.1%

Additional Sources for WRBY Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle